TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -38.46%75.38M | ---- | -38.76%122.48M | ---- | -34.17%200M | ---- | 21.96%303.83M | ---- | 187.86%249.12M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 21.96%-10.71M | ---- | 8.27%-13.72M | ---- | -20.45%-14.96M | ---- | -11.21%-12.42M | ---- | -62.66%-11.17M |
Interest expense - adjustment | ---- | 57.28%17.74M | ---- | -47.99%11.28M | ---- | -30.80%21.68M | ---- | -31.67%31.34M | ---- | 29.52%45.86M |
Impairment and provisions: | ---- | 138.72%3.5M | ---- | -530.22%-9.03M | ---- | -130.34%-1.43M | ---- | 153.94%4.72M | ---- | -136.47%-8.76M |
-Impairment of property, plant and equipment (reversal) | ---- | 51.57%-3.31M | ---- | -102.76%-6.83M | ---- | ---3.37M | ---- | ---- | ---- | 334.77%7.04M |
-Impairmen of inventory (reversal) | ---- | 266.54%8.06M | ---- | 2.75%-4.84M | ---- | -228.72%-4.98M | ---- | 128.79%3.87M | ---- | -297.85%-13.42M |
-Impairment of trade receivables (reversal) | ---- | -147.46%-1.25M | ---- | -61.83%2.64M | ---- | 705.48%6.91M | ---- | 136.23%858K | ---- | -111.71%-2.37M |
Asset sale loss (gain): | ---- | 9.69%6.58M | ---- | 112.51%6M | ---- | -41,075.21%-47.94M | ---- | -98.74%117K | ---- | 218.45%9.27M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2,878.43%-9.53M | ---- | 103.60%343K |
-Loss (gain) on sale of property, machinery and equipment | ---- | 9.69%6.58M | ---- | 192.72%6M | ---- | -167.04%-6.47M | ---- | 8.11%9.65M | ---- | 427.05%8.92M |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---41.47M | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | -5.90%138.45M | ---- | -10.30%147.14M | ---- | -2.37%164.03M | ---- | 1.59%168.01M | ---- | 1.99%165.38M |
-Depreciation | ---- | -3.38%130.26M | ---- | -13.88%134.82M | ---- | --156.56M | ---- | ---- | ---- | 1.99%165.38M |
-Other depreciation and amortization | ---- | -33.46%8.19M | ---- | 64.69%12.31M | ---- | -36.62%7.48M | ---- | --11.8M | ---- | ---- |
Exchange Loss (gain) | ---- | 88.83%-3.14M | ---- | -483.66%-28.13M | ---- | -30.81%7.33M | ---- | 8.25%10.6M | ---- | 137.27%9.79M |
Special items | ---- | -45.89%8.55M | ---- | -31.63%15.8M | ---- | -61.45%23.11M | ---- | 9,776.77%59.95M | ---- | 104.36%607K |
Operating profit before the change of operating capital | ---- | -6.14%236.34M | ---- | -28.43%251.81M | ---- | -37.86%351.83M | ---- | 23.05%566.15M | ---- | 81.70%460.1M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 334.56%136.11M | ---- | -26,157.01%-58.03M | ---- | 98.02%-221K | ---- | 84.92%-11.18M | ---- | -327.28%-74.13M |
Accounts receivable (increase)decrease | ---- | -69.66%23.06M | ---- | 178.15%76M | ---- | -230.83%-97.26M | ---- | 2.79%-29.4M | ---- | -655.86%-30.24M |
Accounts payable increase (decrease) | ---- | -77.91%23.55M | ---- | 965.54%106.6M | ---- | -123.77%-12.32M | ---- | -39.77%51.81M | ---- | 125.18%86.02M |
Special items for working capital changes | ---- | 101.97%457K | ---- | -244.45%-23.18M | ---- | 153.20%16.05M | ---- | 115.18%6.34M | ---- | -662.94%-41.75M |
Cash from business operations | -25.57%127.26M | 18.77%419.51M | 94.05%170.98M | 36.86%353.2M | 74.92%88.11M | -55.79%258.08M | -59.10%50.37M | 45.93%583.72M | 69.41%123.16M | 712.80%400M |
Other taxs | 47.25%-3.36M | -1.87%-12.26M | 13.75%-6.38M | 44.18%-12.04M | 53.18%-7.39M | 59.76%-21.56M | 39.39%-15.79M | -102.07%-53.59M | -151.70%-26.05M | -20.84%-26.52M |
Net cash from operations | -24.73%123.9M | 19.37%407.25M | 103.92%164.6M | 44.24%341.16M | 133.39%80.72M | -55.38%236.52M | -64.39%34.59M | 41.94%530.13M | 55.75%97.12M | 528.21%373.48M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | -21.96%10.71M | ---- | -8.27%13.72M | ---- | 20.45%14.96M | ---- | 11.21%12.42M | ---- | 62.66%11.17M |
Decrease in deposits (increase) | ---- | ---2.45M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of fixed assets | ---- | -52.27%6.57M | ---- | -35.90%13.76M | ---- | 204.96%21.47M | ---- | -68.38%7.04M | ---- | -23.87%22.27M |
Purchase of fixed assets | ---- | -45.59%-546.28M | ---- | -81.74%-375.21M | ---- | -35.13%-206.46M | ---- | -27.87%-152.78M | ---- | 49.22%-119.48M |
Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | -18.44%25.33M | ---- | 176.46%31.05M | ---- | 445.51%11.23M |
Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---6M | ---- | ---- |
Other items in the investment business | 17.89%-209.49M | ---- | -125.31%-255.11M | ---- | -107.67%-113.23M | ---- | 1.06%-54.52M | ---- | -11.58%-55.11M | ---- |
Net cash from investment operations | 17.89%-209.49M | -52.83%-531.45M | -125.31%-255.11M | -140.30%-347.73M | -107.67%-113.23M | -33.65%-144.7M | 1.06%-54.52M | -44.72%-108.27M | -11.58%-55.11M | 63.49%-74.81M |
Net cash before financing | 5.44%-85.59M | -1,792.11%-124.2M | -178.43%-90.51M | -107.15%-6.56M | -63.05%-32.51M | -78.24%91.82M | -147.46%-19.94M | 41.25%421.86M | 223.97%42.01M | 202.24%298.67M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | 104.90%1.43B | ---- | -28.76%698.78M | ---- | 15.63%980.81M | ---- | 12.84%848.25M | ---- | -35.61%751.71M |
Refund | ---- | -77.77%-1.28B | ---- | 28.53%-719.42M | ---- | -10.09%-1.01B | ---- | 9.25%-914.39M | ---- | -7.12%-1.01B |
Interest paid - financing | ---- | -49.66%-16.88M | ---- | 47.99%-11.28M | ---- | 31.30%-21.68M | ---- | 31.30%-31.57M | ---- | -30.60%-45.95M |
Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | -6.14%-44.16M | ---- | -28.29%-41.61M | ---- | -36.60%-32.43M |
Absorb investment income | ---- | ---- | ---- | ---5.03M | ---- | ---- | ---- | 1,842.56%6.8M | ---- | -262.50%-390K |
Other items of the financing business | -28.30%62.68M | 68.86%-14.59M | 1,291.71%87.41M | ---46.86M | -90.67%6.28M | ---- | -61.58%67.32M | ---- | 378.55%175.21M | --237K |
Net cash from financing operations | -28.30%62.68M | 235.21%118.6M | 1,291.71%87.41M | 13.07%-87.72M | -90.67%6.28M | 28.78%-100.9M | -61.58%67.32M | 58.38%-141.68M | 378.55%175.21M | -302.55%-340.42M |
Effect of rate | -84.46%78K | -82.66%260K | -2.52%502K | -46.02%1.5M | 375.40%515K | 114.68%2.78M | -108.24%-187K | -703.45%-18.91M | -17.66%2.27M | -49.49%3.13M |
Net Cash | -639.34%-22.91M | 94.07%-5.59M | 88.18%-3.1M | -937.46%-94.28M | -155.35%-26.23M | -103.24%-9.09M | -78.19%47.38M | 771.04%280.18M | 535.03%217.22M | 66.34%-41.75M |
Begining period cash | -0.54%529.39M | -14.84%532.27M | -14.84%532.27M | -1.00%625.06M | -1.00%625.06M | 70.59%631.37M | 70.59%631.37M | -9.45%370.1M | -9.45%370.1M | -22.38%408.72M |
Cash at the end | -4.37%506.56M | -1.00%526.94M | -11.62%529.68M | -14.84%532.27M | -11.67%599.35M | -1.00%625.06M | 15.09%678.57M | 70.59%631.37M | 63.07%589.59M | -9.45%370.1M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.